Benzinga | Aug 18, 2021 08:31AM EDT

Anixa Biosciences Announces Issuance Of US Patent For Ovarian Cancer Vaccine Technology

Anixa Biosciences, Inc. (NASDAQ:ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that the U.S. Patent and Trademark Office has issued the first U.S. patent for its novel ovarian cancer vaccine technology. This technology was invented and developed at Cleveland Clinic and Anixa is the worldwide licensee. A European patent covering this technology was issued earlier this year.